(VIANEWS) – OGE Energy Corporation (OGE), Eli Lilly and Company (LLY), Grupo Aval Acciones y Valores S.A. ADR (AVAL) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. OGE Energy Corporation (OGE)
61.99% Payout Ratio
OGE Energy Corp., together with its subsidiaries, operates as an energy and energy services provider that offers physical delivery and related services for electricity and natural gas primarily in the south central United States. It operates in two segments, Electric Utility and Natural Gas Midstream Operations. The Electric Utility segment generates, transmits, distributes, and sells electric energy. This segment furnishes retail electric service in 267 communities and their contiguous rural and suburban areas; and owns and operates coal-fired, natural gas-fired, wind-powered, and solar-powered generating assets. Its service area covers 30,000 square miles in Oklahoma and western Arkansas, including Oklahoma City in Oklahoma; and Fort Smith, Arkansas. The Natural Gas Midstream Operations segment engages in gathering, processing, transporting, and storing natural gas; and the provision of crude oil gathering services, and interstate and intrastate natural gas pipeline transportation and storage services primarily to its producer, power plant, local distribution company, and industrial end-user customers. As of December 31, 2019, the company owned and operated interconnected electric generation, transmission, and distribution systems, including 13 generating stations with an aggregate capability of 7,081 megawatts; and transmission systems comprising 53 substations and 5,122 structure miles of lines in Oklahoma, and seven substations and 277 structure miles of lines in Arkansas. Its distribution systems included 350 substations; 29,406 structure miles of overhead lines; 3,050 miles of underground conduit; and 10,967 miles of underground conductors in Oklahoma, as well as 30 substations, 2,786 structure miles of overhead lines, 315 miles of underground conduit, and 679 miles of underground conductors in Arkansas. The company was founded in 1902 and is headquartered in Oklahoma City, Oklahoma.
Earnings Per Share
As for profitability, OGE Energy Corporation has a trailing twelve months EPS of $3.26.
PE Ratio
OGE Energy Corporation has a trailing twelve months price to earnings ratio of 10.55. Meaning, the purchaser of the share is investing $10.55 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.72%.
Moving Average
OGE Energy Corporation’s value is way under its 50-day moving average of $38.25 and way below its 200-day moving average of $38.86.
Volume
Today’s last reported volume for OGE Energy Corporation is 708702 which is 34.32% below its average volume of 1079130.
2. Eli Lilly and Company (LLY)
59.64% Payout Ratio
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramza for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.68.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 50.24. Meaning, the purchaser of the share is investing $50.24 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.64%.
3. Grupo Aval Acciones y Valores S.A. ADR (AVAL)
56.61% Payout Ratio
Grupo Aval Acciones y Valores S.A. provides a range of financial services and products to public and private sector customers in Colombia and Central America. It offers traditional deposit services and products, including checking accounts, savings accounts, time deposits, and other deposits. The company also provides commercial loans comprising general purpose loans, working capital loans, leases, loans funded by development banks, corporate credit cards, and overdraft loans; consumer loans, such as payroll loans, personal loans, automobile and other vehicle loans, credit cards, overdrafts, leases, and general purpose loans; and microcredit and mortgage loans. In addition, the company offers pension and severance fund management services; advice related to capital markets, mergers and acquisitions, project finance, and other transactions; mobile and online banking services; and bancassurance, insurance, trust, bonded warehousing and brokerage transactions, real estate escrow services, merchandise and document storage and deposit, customs agency, cargo management, surety bond and merchandise distribution services, and payment and collection services. Further, it is involved in equity investments in various sectors, including infrastructure, energy and gas, agribusiness, and hospitality; and treasury operations. Grupo Aval Acciones y Valores S.A. was incorporated in 1994 and is headquartered in Bogotá, Colombia.
Earnings Per Share
As for profitability, Grupo Aval Acciones y Valores S.A. ADR has a trailing twelve months EPS of $0.59.
PE Ratio
Grupo Aval Acciones y Valores S.A. ADR has a trailing twelve months price to earnings ratio of 4.05. Meaning, the purchaser of the share is investing $4.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.39%.
Yearly Top and Bottom Value
Grupo Aval Acciones y Valores S.A. ADR’s stock is valued at $2.39 at 20:23 EST, way below its 52-week high of $5.55 and way above its 52-week low of $1.96.
4. Artesian Resources Corporation (ARTNA)
54.59% Payout Ratio
Artesian Resources Corporation, through its subsidiaries, provides water, wastewater, and other services in Delaware, Maryland, and Pennsylvania. The company distributes and sells water to residential, commercial, industrial, governmental, municipal, and utility customers, as well as for public and private fire protection in the states of Delaware, Maryland, and Pennsylvania; and offers wastewater collection, treatment infrastructure, and wastewater services to customers in Delaware. It also provides contract water and wastewater services; water, sewer, and internal service line protection plans; and wastewater management services, as well as design, construction, and engineering services. In addition, the company offers services to other water utilities, including operations and billing functions; owns real estate properties, including land for office buildings, a water treatment plant, and wastewater facility; and provides design, installation, maintenance, and repair services related to existing or proposed storm water management systems. As of December 31, 2021, it served approximately 91,700 customers in Delaware, 2,500 customers in Maryland, and 40 customers in Pennsylvania through 1,368 miles of transmission and distribution mains. Artesian Resources Corporation was founded in 1905 and is headquartered in Newark, Delaware.
Earnings Per Share
As for profitability, Artesian Resources Corporation has a trailing twelve months EPS of $1.88.
PE Ratio
Artesian Resources Corporation has a trailing twelve months price to earnings ratio of 28.12. Meaning, the purchaser of the share is investing $28.12 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.84%.
Sales Growth
Artesian Resources Corporation’s sales growth is 3.7% for the current quarter and 4% for the next.
Yearly Top and Bottom Value
Artesian Resources Corporation’s stock is valued at $52.87 at 20:23 EST, way below its 52-week high of $63.00 and way higher than its 52-week low of $44.08.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 6.4% and a drop 1.9% for the next.
5. Atrion (ATRI)
41.32% Payout Ratio
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
Earnings Per Share
As for profitability, Atrion has a trailing twelve months EPS of $17.44.
PE Ratio
Atrion has a trailing twelve months price to earnings ratio of 36.72. Meaning, the purchaser of the share is investing $36.72 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Volume
Today’s last reported volume for Atrion is 1313 which is 68.33% below its average volume of 4146.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 180.94M for the twelve trailing months.
Moving Average
Atrion’s value is below its 50-day moving average of $647.40 and higher than its 200-day moving average of $621.28.
6. Flushing Financial Corporation (FFIC)
35.2% Payout Ratio
Flushing Financial Corporation operates as the bank holding company for Flushing Bank that provides banking products and services primarily to consumers, businesses, and governmental units. It offers various deposit products, including checking and savings accounts, money market accounts, demand accounts, NOW accounts, and certificates of deposit. The company also provides mortgage loans secured by multi-family residential, commercial real estate, one-to-four family mixed-use property, one-to-four family residential property, and commercial business loans; construction loans; small business administration loans and other small business loans; mortgage loan surrogates, such as mortgage-backed securities; and consumer loans, including overdraft lines of credit, as well as the United States government securities, corporate fixed-income securities, and other marketable securities. In addition, it offers banking services to public municipalities comprising counties, cities, towns, villages, school districts, libraries, fire districts, and various courts. As of December 31, 2021, the company operated 24 full-service offices located in the New York City boroughs of Queens, Brooklyn, and Manhattan; and in Nassau and Suffolk County, New York, as well as an Internet branch. Flushing Financial Corporation was founded in 1929 and is based in Uniondale, New York.
Earnings Per Share
As for profitability, Flushing Financial Corporation has a trailing twelve months EPS of $2.55.
PE Ratio
Flushing Financial Corporation has a trailing twelve months price to earnings ratio of 6.35. Meaning, the purchaser of the share is investing $6.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.34%.
Sales Growth
Flushing Financial Corporation’s sales growth is negative 15.5% for the present quarter and negative 24.8% for the next.
Volume
Today’s last reported volume for Flushing Financial Corporation is 61086 which is 64.71% below its average volume of 173145.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 8, 2023, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 5.65%.
Yearly Top and Bottom Value
Flushing Financial Corporation’s stock is valued at $16.20 at 20:23 EST, way under its 52-week high of $23.64 and higher than its 52-week low of $14.84.
